Investors Have Until November 2, 2026, to Seek Lead Plaintiff Status in Hims & Hers Suit
News provided byHims & Hers Health, Inc · 1 min read
RADNOR, Pa., Investors who purchased Hims & Hers Health, Inc. (HIMS) securities between August 4, 2025, and July 29, 2026, have until November 2, 2026, to seek lead plaintiff status in a securities fraud class action lawsuit filed against the company. The lawsuit, filed by the law firm Kessler Topaz Meltzer & Check, LLP, alleges that HIMS engaged in deceptive and unlawful privacy practices, misrepresenting to investors how it handles consumer health information.
According to the complaint, HIMS shared consumers' medical information with third-party advertising platforms, leading the Federal Trade Commission (FTC) to file a lawsuit accusing the company of "deceptive and unlawful privacy practices." Specifically, the FTC alleged that HIMS shared sensitive patient data with companies like Meta Platforms, the parent of Facebook and Snap.
The lawsuit claims that HIMS failed to disclose several key pieces of information to investors, including that the company charges consumers for prescriptions immediately after they submit an intake form, despite promising to consult with a medical provider to find the right treatment. These practices, the complaint states, subjected HIMS to regulatory scrutiny, potentially leading to significant financial penalties.
On the heels of the FTC's lawsuit, HIMS's stock price fell by $4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026.
Investors affected by these allegations are encouraged to file for lead plaintiff status by November 2, 2026, through Kessler Topaz Meltzer & Check, LLP. The firm offers free case evaluations and representation on a contingency fee basis, meaning investors do not pay unless they recover funds.
"We are committed to protecting the interests of HIMS investors who have suffered losses due to the company's alleged deceptive practices," said Naji.
The firm's website also provides detailed information on the case and how to get involved. "We urge investors to act quickly to ensure their rights are protected," added Naji.